Boston Scientific, in late January 2021, signed an agreement to take full ownership of mobile cardiac health solutions and services provider Preventice Solutions in a deal that values 100% of the latter at up to $1.25 billion. The consideration includes $925 million in upfront cash payment and an additional payment of up to $300m based […]